Epigene Labs announces multi-year expansion of collaboration with Servier
This partnership aims to accelerate and increase precision of Servier’s oncology clinical trials enabled by Epigene’s mCUBE platform.
Le Point magazine unveils its 2025 inventors’ rankings – the 100 inventions that will change our lives (French read)
Behind every invention lies an innovative vision, a bet on human intelligence, and a promise: to reconcile progress with hope.
Sifted, backed by FT, includes Epigene Labs in its 2024 investment-grade research on drug discovery
Find the European drug discovery market map with the 64 startups selected by Sifted, from pre-seed to Series A.
Epigene Labs: a future champion of precision oncology?
Discover how our cutting-edge approach and groundbreaking advances are shaping the future of precision oncology in Biotech Finances.
The EIC fund materializes its support to Epigene Labs to accelerate precision oncology R&D
This investment heralds outstanding
technological and scientific strides made by Epigene Labs, which also received a multimillion grant last year as part of the EIC Accelerator program.
Epigene Labs partners with Servier to launch a new application in the field of oncology
Servier has partnered with Epigene Labs to develop an AI-powered application that prioritizes new cancer drug targets. The solution aims to support therapeutic decision-making and will be integrated into Servier’s R&D to accelerate innovation in oncology.
STATION F unveils TOP30 2020, its group featuring the most advanced startups of the campus
STATION F reveals its TOP30 2020, highlighting the most advanced startups on campus. Discover the innovators who raised over €60M.
Epigene Labs and Institut Curie announce a partnership to improve ovarian cancer treatment
Epigene Labs and Institut Curie have initiated a strategic partnership to accelerate the discovery of ovarian cancer biomarkers and therapeutic targets. By leveraging Epigene’s AI-powered molecular data platform, the collaboration will support translational research using Institut Curie’s high-throughput sequencing data.
Epigene Labs raises 1.4 million euros
Learn how Epigene Labs raised €1.4M to accelerate AI-driven genomic data analysis, revolutionizing oncology drug discovery.
TICPharma, leading French-speaking healthcare and pharma news website, features Epigene Labs
Featured in TICPharma, discover how our platform identifies biomarkers new cancer drug targets.
